Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue    
Total revenues $ 56,749 $ 0
Operating costs and expenses:    
Research and development (359,651) (463,782)
General and administrative (927,880) (863,373)
Total operating costs and expenses (1,287,531) (1,327,155)
Loss from operations (1,230,782) (1,327,155)
Other income (expense):    
Other expense (134) (245)
Interest income, net 51,487 150
Total other income (expense) 51,353 (95)
Net loss (1,179,429) (1,327,250)
Deemed dividend 0 (3,879,447)
Net loss applicable to common stockholders $ (1,179,429) $ (5,206,697)
Basic and diluted loss per share $ (0.19) $ (6.45)
Weighted-average shares of common stock outstanding, basic and diluted 6,233,331 806,976
Royalty [Member]    
Revenue    
Total revenues $ 56,749 $ 0